Hormone therapy, osteoporosis treatments and hybrid health care with Risa Kagan, MD

Video
Conferences|The Menopause Society

We caught up with Risa Kagan, MD, at the North American Menopause Society's 2021 Annual Meeting to hear about her role on the Scientific Planning Committee and this year's takeaways.

Risa Kagan, MD, FACOG, is an ob/gyn and clinical professor at the University of California San Francisco. She currently serves on the NAMS Board of Trustees.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!
Recent Videos
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
Non-hormonal treatments offer relief for genitourinary syndrome of menopause | Image Credit: providers.uthscsa.edu.
Jill Liss, MD, MSCP, FACOG, associate clinical professor, OB/GYN, at the University of Colorado School of Medicine.
Related Content
Epigenetic aging linked to increased colorectal cancer risk in postmenopausal women | Image Credit: © Rasi - stock.adobe.com.

Epigenetic aging linked to increased colorectal cancer risk in postmenopausal women

Morgan Ebert, Managing Editor
August 21st 2025
Article

Read More

S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person

S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person

Lindsey Carr, Editor
August 21st 2025
Podcast

Listen

Frequent sit-to-stand transitions reduce diastolic blood pressure in postmenopausal women | Image Credit: © Chinnapong - stock.adobe.com.

Frequent sit-to-stand transitions reduce diastolic blood pressure in postmenopausal women

Morgan Ebert, Managing Editor
August 21st 2025
Article

Read More

S3 E19: Alyssa Dweck, MD, on menopause products, her podcast, and more

S3 E19: Alyssa Dweck, MD, on menopause products, her podcast, and more

Lindsey Carr, Editor;Michael Krychman, MD
August 21st 2025
Podcast

Listen

FDA extends review period for Bayer's elinzanetant for vasomotor symptoms | Image credit: Contemporary OB/GYN

FDA extends review period for Bayer's elinzanetant for vasomotor symptoms

Morgan Ebert, Managing Editor
August 21st 2025
Article

Read More

Contemporary OB/GYN week in review: hormone therapies, PAS guidelines, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: HSDD treatment, PAS guidelines, and more

Celeste Krewson, Assistant Editor
August 21st 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.